Author of the publication

A predictive probability design for phase II cancer clinical trials.

, and . Clinical trials (London, England), 5 (2): 93-106 (January 2008)5653<m:linebreak></m:linebreak>GR: CA97007/CA/NCI NIH HHS/United States; JID: 101197451; 0 (Antineoplastic Agents); ppublish;<m:linebreak></m:linebreak>Fase II.
DOI: 10.1177/1740774508089279

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

 

Other publications of authors with the same name

A predictive probability design for phase II cancer clinical trials., and . Clinical trials (London, England), 5 (2): 93-106 (January 2008)5653<m:linebreak></m:linebreak>GR: CA97007/CA/NCI NIH HHS/United States; JID: 101197451; 0 (Antineoplastic Agents); ppublish;<m:linebreak></m:linebreak>Fase II.CoxPhLb: An R Package for Analyzing Length Biased Data under Cox Model., , , , and . R J., 12 (1): 118 (2020)drexplorer: A tool to explore dose-response relationships and drug-drug interactions., , , , , , , , and . Bioinform., 31 (10): 1692-1694 (2015)